EGFRAP encodes a new negative regulator of the EGFR acting in both normal and oncogenic EGFR/Ras-driven tissue morphogenesis
Open Access
- 19 August 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 17 (8) , e1009738
Abstract
Activation of Ras signaling occurs in ~30% of human cancers. However, activated Ras alone is insufficient to produce malignancy. Thus, it is imperative to identify those genes cooperating with activated Ras in driving tumoral growth. In this work, we have identified a novel EGFR inhibitor, which we have namedEGFRAP, forEGFR adaptorprotein. Elimination ofEGFRAPpotentiates activated Ras-induced overgrowth in theDrosophilawing imaginal disc. We show that EGFRAP interacts physically with the phosphorylated form of EGFR via its SH2 domain. EGFRAP is expressed at high levels in regions of maximal EGFR/Ras pathway activity, such as at the presumptive wing margin. In addition, EGFRAP expression is up-regulated in conditions of oncogenic EGFR/Ras activation. Normal and oncogenic EGFR/Ras-mediated upregulation of EGRAP levels depend on the Notch pathway. We also find that elimination ofEGFRAPdoes not affect overall organogenesis or viability. However, simultaneous downregulation of EGFRAP and its ortholog PVRAP results in defects associated with increased EGFR function. Based on these results, we propose thatEGFRAPis a new negative regulator of the EGFR/Ras pathway, which, while being required redundantly for normal morphogenesis, behaves as an important modulator of EGFR/Ras-driven tissue hyperplasia. We suggest that the ability ofEGFRAPto functionally inhibit the EGFR pathway in oncogenic cells results from the activation of a feedback loop leading to increaseEGFRAPexpression. This could act as a surveillance mechanism to prevent excessive EGFR activity and uncontrolled cell growth.Keywords
Funding Information
- Spanish Agencia Estatal de Investigación (BFU2016-80797-R)
- Spanish Agencia Estatal de Investigación (PID2019-109013GB-100)
- Spanish Agencia Estatal de Investigación (MDM-2016-0687)
- Spanish Agencia Estatal de Investigación (PGC2018-094476-B-100)
- Spanish Agencia Estatal de Investigación (BFU2015-67266-R)
- consejería de educación e investigación, comunidad de madrid (S2010/BMD-2305)
- European Regional Development Fund
- Junta de Andalucía
- MICINN (FPI Fellowship)
This publication has 88 references indexed in Scilit:
- Apoptotic cells can induce non-autonomous apoptosis through the TNF pathwayeLife, 2013
- Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeuticsNature Reviews Cancer, 2013
- EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- Oncogenic cooperation between SOCS family proteins and EGFR identified using a Drosophila epithelial transformation modelGenes & Development, 2012
- The Hippo pathway regulates apical-domain size independently of its growth-control functionJournal of Cell Science, 2009
- Prognostic Relevance of Tensin4 Expression in Human Gastric CancerAnnals of Surgical Oncology, 2008
- Tensins: A New Switch in Cell MigrationDevelopmental Cell, 2007
- A module of negative feedback regulators defines growth factor signalingNature Genetics, 2007
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- Localization of DER and the pattern of cell divisions in wild-type and Ellipse eye imaginal discsDevelopmental Biology, 1992